Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 8—August 2018

Enhanced Surveillance for Coccidioidomycosis, 14 US States, 2016

Kaitlin BenedictComments to Author , Malia Ireland, Meghan P. Weinberg, Randon J. Gruninger, Jenna Weigand, Lei Chen, Katharine Perez-Lockett, Catherine Bledsoe, Lynn Denny, Katie Cibulskas, Suzanne Gibbons-Burgener, Anna Kocharian, Emilio DeBess, Tracy K. Miller, Alicia Lepp, Laura Cronquist, Kimberly Warren, Jose Antonio Serrano, Cody Loveland, George Turabelidze, Orion McCotter, and Brendan R. Jackson
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Benedict, O. McCotter, B.R. Jackson); Minnesota Department of Health, St. Paul, Minnesota, USA (M. Ireland); Michigan Department of Health and Human Services, Lansing, Michigan, USA (M.P. Weinberg); Utah Department of Health, Salt Lake City, Utah, USA (R.J. Gruninger); Southwest Utah Public Health Department, Cedar City, Utah, USA (J. Weigand); Washoe County Health District, Reno, Nevada, USA (L. Chen); New Mexico Department of Health, Las Cruces, New Mexico, USA (K. Perez-Lockett, C. Bledsoe); Ohio Department of Health, Columbus, Ohio, USA (L. Denny, K. Cibulskas); Wisconsin Division of Public Health, Madison, Wisconsin, USA (S. Gibbons-Burgener, A. Kocharian); Public Health Division, Oregon Health Authority, Portland, Oregon, USA (E. DeBess); North Dakota Department of Health, Bismarck, North Dakota, USA (T.K. Miller, A. Lepp, L. Cronquist); Pennsylvania Department of Health, Wilkes-Barre, Pennsylvania, USA (K. Warren); Louisiana Department of Health, Baton Rouge, Louisiana, USA (J.A. Serrano); Wyoming Department of Health, Cheyenne, Wyoming, USA (C. Loveland); Missouri Department of Health and Senior Services, St. Louis, Missouri, USA (G. Turabelidze)

Main Article

Table 1

Demographic features and underlying medical conditions of coccidioidomycosis patients in 14 low-endemic and nonendemic US states, 2016*

Characteristic Value
Total no. patients
186 (100)
M 109 (59)
F 77 (41)
Median age, y (range), n = 185 65 (7–91)
Race, n = 170
White 151 (89)
  Black/African American 9 (5)
  Asian 1 (0.6)
  American Indian or Alaska Native 3 (2)
  Other 6 (4)
Hispanic or Latino, n = 175 19 (11)
Health insurance coverage, n = 158 148 (94)
Some college education or higher, n = 137 91 (66)
Annual household income >$50,000, n = 104
56 (54)
Underlying medical conditions
Smoking, n = 171
Currently 10 (6)
In the past 74 (43)
None 87 (51)
Asthma requiring an inhaler 20 (11)
COPD or emphysema 18 (10)
Other lung disease 13 (7)
Diabetes 35 (19)
HIV/AIDS 2 (1)
Heart disease 35 (19)
Cancer 32 (17)
Transplant 2 (1)
Liver disease 9 (5)
Kidney disease 9 (5)
Other major illness 49 (26)
No underlying medical conditions reported 61 (34)
Immunosuppressed† 36 (19)
Immunosuppressive medications, n = 165 32 (19)
History of coccidioidomycosis, n = 174 12 (7)

*Values are no. (%) patients except as indicated. n values are provided for categories with <186 responses.
†Defined as HIV/AIDS, solid organ or bone marrow transplant, or immunosuppressive medication use.

Main Article

Page created: July 17, 2018
Page updated: July 17, 2018
Page reviewed: July 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.